José Abad-Rodríguez

Dr. José Abad-Rodríguez

Membrane Biology and Axonal Repair Laboratory, Hospital Nacional de Parapléjicos (SESCAM), Finca La Peraleda s/n, 45071 Toledo, Spain
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2004 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
José Abad-RodríguezJosé Abad-Rodríguez
José Abad-Rodríguez
MLMaria Dolores Ledesma
Maria Dolores Ledesma
KCKatleen Craessaerts
Katleen Craessaerts
SPSimona Perga
Simona Perga
Miguel MedinaMiguel Medina
Miguel Medina
CDCarlos G. Dotti
Carlos G. Dotti
Recent experimental and clinical retrospective studies support the view that reduction of brain cholesterol protects against Alzheimer's disease (AD). However, genetic and pharmacological evidence indicates that low brain cholesterol leads to neurodegeneration. This apparent contradiction prompted us to analyze the role of neuronal cholesterol in amyloid peptide generation in experimental systems that closely resemble physiological and pathological situations. We show that, in the hippocampus of control human and transgenic mice, only a small pool of endogenous APP and its β-secretase, BACE 1, are found in the same membrane environment. Much higher levels of BACE 1–APP colocalization is found in hippocampal membranes from AD patients or in rodent hippocampal neurons with a moderate reduction of membrane cholesterol. Their increased colocalization is associated with elevated production of amyloid peptide. These results suggest that loss of neuronal membrane cholesterol contributes to excessive amyloidogenesis in AD and pave the way for the identification of the cause of cholesterol loss and for the development of specific therapeutic strategies.

17 April 2005 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JSJorge Santos Da Silva
Jorge Santos Da Silva
THTakafumi Hasegawa
Takafumi Hasegawa
TMTaeko Miyagi
Taeko Miyagi
CDCarlos G Dotti
Carlos G Dotti
José Abad-RodríguezJosé Abad-Rodríguez
José Abad-Rodríguez

1 November 2001 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
José Abad-RodríguezJosé Abad-Rodríguez
José Abad-Rodríguez
EPEugenia Piddini
Eugenia Piddini
THTakafumi Hasegawa
Takafumi Hasegawa
TMTaeko Miyagi
Taeko Miyagi
CDCarlos G. Dotti
Carlos G. Dotti
It has been long recognized that the ganglioside GM1 plays a role in axonal growth and neuronal differentiation. However, the involvement of plasma membrane GM1 has been difficult to elucidate. This is possible now thanks to the recent cloning of plasma membrane ganglioside sialidase (PMGS), the enzyme responsible for the localized hydrolysis of oligosialogangliosides into GM1. In this work we show that PMGS mRNA and protein levels are high at early developmental stages of the hippocampus and low in adulthood both in vivo and in vitro. We also demonstrate that inhibition of PMGS activity blocks axonal elongation, whereas the increase in PMGS activity dramatically enhances axon growth and accelerates the polarization of cytoskeletal proteins. Finally, we show that axotomy close to the cell body in PMGS overexpressing neurons results in the regrowth of the original axon instead of randomly, as is the case in control neurons. In all, these results imply that PMGS activity through the modulation of GM1 surface levels is an important component of the machinery controlling axonal growth. We hypothesize that increasing PMGS activity in the adult nervous system may be useful to improve regeneration after nerve damage.

1 December 2003 in EMBO Reports
Verified
Journal Article
Open access
PDF file
MLMaria Dolores Ledesma
Maria Dolores Ledesma
José Abad-RodríguezJosé Abad-Rodríguez
José Abad-Rodríguez
CGCristian Galvan
Cristian Galvan
EBElisa Biondi
Elisa Biondi
Pilar NavarroPilar Navarro
Pilar Navarro
CDCarlos G Dotti
Carlos G Dotti
The serine protease plasmin can efficiently degrade amyloid peptide in vitro , and is found at low levels in the hippocampus of patients with Alzheimer's disease (AD). The cause of such paucity remains unknown. We show here that the levels of total brain plasminogen and plasminogen‐binding molecules are normal in these brain samples, yet plasminogen membrane binding is greatly reduced. Biochemical analysis reveals that the membranes of these brains have a mild, still significant, cholesterol reduction compared to age‐matched controls, and anomalous raft microdomains. This was reflected by the loss of raft‐enriched proteins, including plasminogen‐binding and ‐activating molecules. Using hippocampal neurons in culture, we demonstrate that removal of a similar amount of membrane cholesterol is sufficient to induce raft disorganization, leading to reduced plasminogen membrane binding and low plasmin activity. These results suggest that brain raft alterations may contribute to AD by rendering the plasminogen system inefficient.

1 March 2011 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
GCGuillermo de Cárcer
Guillermo de Cárcer
BEBeatriz Escobar
Beatriz Escobar
AHAlonso M. Higuero
Alonso M. Higuero
LGLaura García
Laura García
AAAlejandra Ansón
Alejandra Ansón
MMMarcos Malumbres
Marcos Malumbres
Polo-like kinases (Plks) are characterized by the presence of a specific domain, known as the polo box (PBD), involved in protein-protein interactions. Plk1 to Plk4 are involved in centrosome biology as well as the regulation of mitosis, cytokinesis, and cell cycle checkpoints in response to genotoxic stress. We have analyzed here the new member of the vertebrate family, Plk5, a protein that lacks the kinase domain in humans. Plk5 does not seem to have a role in cell cycle progression; in fact, it is downregulated in proliferating cells and accumulates in quiescent cells. This protein is mostly expressed in the brain of both mice and humans, and it modulates the formation of neuritic processes upon stimulation of the brain-derived neurotrophic factor (BDNF)/nerve growth factor (NGF)-Ras pathway in neurons. The human PLK5 gene is significantly silenced in astrocytoma and glioblastoma multiforme by promoter hypermethylation, suggesting a tumor suppressor function for this gene. Indeed, overexpression of Plk5 has potent apoptotic effects in these tumor cells. Thus, Plk5 seems to have evolved as a kinase-deficient PBD-containing protein with nervous system-specific functions and tumor suppressor activity in brain cancer.

12 January 2013 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
SVSilvia Velasco
Silvia Velasco
NDNatalia Díez‐Revuelta
Natalia Díez‐Revuelta
THTeresa Hernández‐Iglesias
Teresa Hernández‐Iglesias
HKHerbert Kaltner
Herbert Kaltner
SASabine André
Sabine André
José Abad-RodríguezJosé Abad-Rodríguez
José Abad-Rodríguez
Axon membrane glycoproteins are essential for neuronal differentiation, although the mechanisms underlying their polarized sorting and organization are poorly understood. We describe here that galectin‐4 (Gal‐4), a lectin highly expressed in gastrointestinal tissues and involved in epithelial glycoprotein transport, is expressed by hippocampal and cortical neurons where it is sorted to discrete segments of the axonal membrane in a microtubule‐ and sulfatide‐dependent manner. Gal‐4 knockdown retards axon growth, an effect that can be rescued by recombinant Gal‐4 addition. This Gal‐4 reduction, as inhibition of sulfatide synthesis does, lowers the presence and clustered organization of axon growth‐promoting molecule NCAM L1 at the axon membrane. Furthermore, we find that Gal‐4 interacts with L1 by specifically binding to LacNAc branch ends of L1 N‐glycans. Impairing the maturation of these N‐glycans precludes Gal‐4/L1 association resulting in a failure of L1 membrane cluster organization. In all, Gal‐4 sorts to axon plasma membrane segments by binding to sulfatide‐containing microtubule‐associated carriers and being bivalent, it organizes the transport of L1, and likely other axonal glycoproteins, by attaching them to the carriers through their LacNAc termini. This mechanism would underlie L1 functional organization on the plasma membrane, required for proper axon growth.